Cytodyn has had it’s own shot at that bar, a reminder
Cytodyn has had it’s own shot at that bar, a reminder there were GBM patients in the solid tumor basket trial and there were some patients in the TNBC Leronlimab trial with glioblastoma secondary tumors that were ALSO responding to Leronlimab. As we know, this drug does cross the blood brain barrier, so it is open season for high CCR5 expressing brain tumors…glioblastoma among them but also astrocyte’s so by inference probably this includes astrocytoma’s. The preclinical study Dr. Jay announced where Cytodyn just supplies the drug will act as an accelerant. I’m not surprised that among his 4 near term priorities is to get the data they are sitting on published…the medical oncology community needs to be aware of it. Glioblastoma diagnosis is bleak, if memory serves 5% 5 year survival. We need this drug out of the barn and on the run against the subset of cancers it can bend that survival curve.
19
1
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Exciting Upcoming Financial Announcement from Beta Bionics Beta Bionics, Inc. (Nasdaq: BBNX) is gearing up for an important milestone as it prepares to share its first quarter financial results. This release will take place after market closure on a specified day, allowing analysts and investors to absorb the implications of the report. Following the release, management...
Continue Reading
New Leadership to Drive Expansion In a boost to its commitment to scaling up, Castillo Engineering, based in Maitland, Florida, has roped in two veterans from the renewables sector as vice presidents. Aaron Carrillo and Devin Radovich, who share a history of successful collaboration at Renewable Energy Systems Americas (RES), are set to guide Castillo's growth in the...
Continue Reading
Prosafe SE Achieves Notable Fleet Utilization In April, Prosafe SE's fleet saw a solid utilization rate of 58 percent, marking a positive performance for the leading operator of semi-submersible accommodation vessels. During this month, their standout vessels, Safe Zephyrus and Safe Eurus, operated at an impressive 100 percent commercial uptime, showcasing the company's...
Continue Reading
Understanding the Class Action Lawsuit for iLearningEngines, Inc. For investors of iLearningEngines, Inc., the ongoing developments regarding a class action lawsuit present a vital opportunity to engage in protecting their investments. The law firm representing investors, renowned for its achievements in securities class actions, has highlighted that all purchasers of...
Continue Reading
Understanding the Current Economic Landscape Recent moves by the U.S. Federal Reserve have sparked conversations among economists about possible shifts in monetary policy across Europe. Analysts are keeping a close eye on how the Fed's actions might affect the European Central Bank (ECB) in the months ahead. Even with cuts from the Fed, the landscape facing the ECB is...
Continue Reading
